Stock CANSF WILLOW BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Willow Biosciences Inc. OTC Markets

Equities

CANSF

CA97111B4047

Market Closed - OTC Markets
Other stock markets
 19:52:25 04/06/2024 BST 		5-day change 1st Jan Change
0.084 USD 0.00% Intraday chart for Willow Biosciences Inc. +41.65% +20.17%
06-03 Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday MT
06-03 Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Willow Biosciences to Raise Up to $3 Million Via Brokered Private Placement; Shares Jumped 24% on Friday
MT
Willow Biosciences Brief: Announcing Brokered Private Placement Offering To Raise Up To $3 Million
MT
WILLOW ANNOUNCES BROKERED PRIVATE PLACEMENT OFFERING TO RAISE UP TO $3.0 MILLION
AQ
Willow Biosciences Inc. announced that it expects to receive CAD 3 million in funding
CI
Willow Biosciences Signs Multi-Product Development, Licensing Partnership With Laurus Lab
MT
Willow Biosciences Brief: Announcing Multi-product Development and Licensing Partnership With Laurus Lab
MT
Willow Biosciences Inc. Announces Multi-Product Development and Licensing Partnership with Laurus Labs
CI
WILLOW ANNOUNCES MULTI-PRODUCT DEVELOPMENT AND LICENSING PARTNERSHIP WITH LAURUS LABS FOR MANUFACTURING ACTIVE PHARMACEUTICAL INGREDIENTS
AQ
Willow Biosciences Brief: Reiterating its Expectations of at least doubling its full year 2024 revenues, As Reports Q1 Results
MT
Willow Biosciences Inc. Provides Earnings Guidance for the Fiscal Year 2024
CI
Willow Biosciences Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Willow Biosciences Narrows 2023 Loss YOY
MT
Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
WILLOW BIOSCIENCES REPORTS FOURTH QUARTER AND FISCAL YEAR 2023 FINANCIALS AND OPERATIONS AND FILING OF ITS 2023 AIF
AQ
Willow Biosciences Announces Second Strategic Investment From Kalsec
MT
Willow Biosciences Secures Strategic Investment From Kalsec to Develop Natural Food Ingredient
MT
Willow Biosciences Inc. announced that it expects to receive funding from Kalsec Inc.
CI
Willow Biosciences Enters Partnership With Global Ingredient Manufacturer
MT
Willow Biosciences Inc. Announces Collaboration with Global Active Pharmaceutical Ingredient Manufacturer to Develop A More Sustainable, Cost-Effective Manufacturing Process for A Large Volume Global Market
CI
WILLOW ANNOUNCES COLLABORATION WITH GLOBAL INGREDIENT MANUFACTURER TO DEVELOP A MORE COST-EFFECTIVE, SUSTAINABLE PROCESS FOR A LARGE VOLUME ACTIVE PHARMACEUTICAL INGREDIENT
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. WLLW Stock
  4. CANSF Stock
  5. News Willow Biosciences Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW